Cargando…
New drugs for migraine
After the triptans, a calcitonin gene-related peptide blocker (telcagepant) is the first acute medicine that has been developed primarily for treatment of acute migraine. Otherwise, the new drugs have been developed first for other purposes, like anticonvulsants, antihypertensives and antidepressant...
Autores principales: | Stovner, Lars Jacob, Tronvik, Erling, Hagen, Knut |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476209/ https://www.ncbi.nlm.nih.gov/pubmed/19795182 http://dx.doi.org/10.1007/s10194-009-0156-9 |
Ejemplares similares
-
FollowTheSutures: Piloting a new way to administer onabotulinumtoxinA for chronic migraine
por: Stovner, Lars Jacob, et al.
Publicado: (2022) -
The crossover design for migraine preventives: an analyses of four randomized placebo-controlled trials
por: Jenssen, Astrid Bjørke, et al.
Publicado: (2019) -
Association between blood pressure measures and recurrent headache in adolescents: cross-sectional data from the HUNT-Youth study
por: Tronvik, Erling, et al.
Publicado: (2011) -
Pilot study of sphenopalatine injection of onabotulinumtoxinA for the treatment of intractable chronic migraine
por: Bratbak, Daniel Fossum, et al.
Publicado: (2016) -
Angiotensin-converting enzyme gene insertion/deletion polymorphism in migraine patients
por: Tronvik, Erling, et al.
Publicado: (2008)